WCN26-3831 Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients with End-Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model” (SMART study)

Read full text Summarise with VIRAT
Authors: Gopal Krishna Prasad Chemiti, Mark Durst, Chenlee Condie, Mikhail Toupikov, Seth Southwick, Anitha Vijayan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Management of anemia in patients with ESRD is a labor-intensive process as hemoglobin (Hb) targets must be evaluated regularly, and frequent erythropoietin stimulating agent (ESA) dose adjustments are required to be maintained Hb in a narrow therapeutic range. Exceeding the Hb target or not achieving it can lead to adverse events. In this single center study, artificial intelligence and predictive algorithm was created to individualize patient dosing of ESA in patients with ESRD. We hypothesized that a computer based predictive algorithm can individualize ESA dosing leading to reduced ESA use, thereby reducing cost, while maintaining Hb in the recommended target range.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management Iron Metabolism and Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104058–104058
Publication date
25 March 2026
Language
EN